Evidence map›Paper›PMID 30566500›Full record

SynthesisPLoS genetics2018

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.

Felix Day, Tugce Karaderi, Michelle R Jones, Cindy Meun, Chunyan He, Alex Drong, Peter Kraft, Nan Lin, Hongyan Huang, Linda Broer and 40 more

Erratum issued Registry-linked trialOpen access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07490964 (Pathogenesis of Functional Hyperandrogenism in Women With Type 1 Diabetes Mellitus), which is not on this map. Cited by 312 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
312citing papers in PubMed, 13 pooled it
42.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07490964 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Pathogenesis of Functional Hyperandrogenism in Women With Type 1 Diabetes Mellitus: From Genetic-molecular Mechanisms to Clinical Phenotype.

TypeobservationalSponsorFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalRan2026 to 2028Enrolled60ConditionsType 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)ArmsType 1 diabetes mellitus, Elevated circulating androgen levels, Sex dimorphism
3 · Its place in the literature

Who cites it

312 citing papers in PubMed, 13 syntheses or guidelines pooled it, 669 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Review
  16. Article
  17. Article
  18. Review
  19. Integrative Multi-omics Analysis for Prioritization of Candidate Genes in Polycystic Ovary Syndrome.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  20. Article

252 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

50 authors at 20 institutions in 12 countries.

Felix DayMRC Epidemiology Unit, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.ORCID 0000-0003-3789-7651
Tugce KaraderiThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Michelle R JonesCenter for Bioinformatics & Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Cindy MeunDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-6970-0852
Chunyan HeDepartment of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.
Alex DrongThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Peter KraftDepartments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Nan LinDepartment of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.
Hongyan HuangDepartments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Linda BroerDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Reedik MagiEstonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
Richa SaxenaBroad Institute of Harvard and MIT and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Triin LaiskEstonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID 0000-0003-1501-9030
Margrit UrbanekDivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
M Geoffrey HayesDivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Gudmar ThorleifssondeCODE genetics/Amgen, Reykjavik, Iceland.
Juan Fernandez-TajesThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Anubha MahajanThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-5585-3420
Benjamin H MullinDepartment of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Bronwyn G A StuckeyDepartment of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Timothy D SpectorDepartment of Twin Research & Genetic Epidemiology, King's College London, London, United Kingdom.
Scott G WilsonDepartment of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Mark O GoodarziDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Lea DavisDepartment of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Barbara Obermayer-PietschDivision of Endocrinology and Diabetology, Department of Internal Medicine Medical University of Graz, Graz, Austria.
André G UitterlindenDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Verneri AnttilaStanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-0073-4675
Benjamin M NealeStanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.ORCID 0000-0003-1513-6077
Marjo-Riitta JarvelinDepartment of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0002-2149-0630
Bart FauserDepartment of Reproductive Medicine and Gynaecology, University Medical Center, Utrecht, The Netherlands.
Irina KowalskaDepartment of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Białystok, Poland.
Jenny A VisserDepartment of Internal Medicine, Section of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0001-7182-3571
Marianne AndersenOdense University Hospital, University of Southern Denmark, Odense, Denmark.
Ken OngMRC Epidemiology Unit, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.ORCID 0000-0003-4689-7530
Elisabet Stener-VictorinDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3424-1502
David EhrmannDepartment of Medicine, Section of Adult and Paediatric Endocrinology, Diabetes, and Metabolism, The University of Chicago, Chicago, Illinois, United States of America.
Richard S LegroDepartment of Obstetrics and Gynecology and Public Health Sciences, Penn State University College of Medicine, Hershey, Pennsylvania, United States of America.
Andres SalumetsDepartment of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.ORCID 0000-0002-1251-8160
Mark I McCarthyThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Laure Morin-PapunenDepartment of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Medical Research Center, PEDEGO Research Unit, Oulu, Finland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Reykjavik, Iceland.ORCID 0000-0002-7049-2827
Kari StefanssondeCODE genetics/Amgen, Reykjavik, Iceland.
23andMe Research Team
Unnur StyrkarsdottirdeCODE genetics/Amgen, Reykjavik, Iceland.ORCID 0000-0001-8146-8278
John R B PerryMRC Epidemiology Unit, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Andrea DunaifDivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.ORCID 0000-0002-8175-4677
Joop LavenDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Steve FranksInstitute of Reproductive & Developmental Biology, Department of Surgery & Cancer, Imperial College London, London, United Kingdom.
Cecilia M LindgrenThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Corrine K WeltDivision of Endocrinology, Metabolism and Diabetes, University of Utah, Salt Lake City, Utah, United States of America.ORCID 0000-0002-8219-5504
Centre for Human Genetics · GBErasmus MC · NLBroad Institute · USdeCODE Genetics (Iceland) · ISNorthwestern University · USThe University of Western Australia · AUUniversity of Cambridge · GBCedars-Sinai Medical Center · USHarvard University · USOulu University Hospital · FIUniversity of Kentucky · USUniversity of Tartu · EEImperial College London · GBKarolinska Institutet · SEKing's College London · GBMedical University of Białystok · PLMedical University of Graz · ATPenn State Milton S. Hershey Medical Center · USUniversity Medical Center Utrecht · NLUniversity of Chicago · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Role of Androgen Excess in Provoking Oxidative Stress in FemalesP50HD044405 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DUNAIF, ANDREA E · 2002 to 2017
$17.2M
The Genetic Determinants of Human GNRH DeficiencyP50HD028138 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI SEMINARA, STEPHANIE BETH · 2014 to 2020
$12.9M
Post-Diabetes Prevention Program (DPP)U01DK048381 · NIDDK · UNIVERSITY OF CHICAGO · PI EHRMANN, DAVID A · 1994 to 2021
$9.6M
Genome-Wide Association Scan of Polycystic Ovary Syndrome PhenotypesR01HD057223 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DUNAIF, ANDREA E · 2009 to 2010
$5.3M
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea TreatmentU01DK094431 · NIDDK · UNIVERSITY OF CHICAGO · PI EHRMANN, DAVID A, VAN CAUTER, EVE · 2011 to 2015
$5.1M
COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORKU10HD038992 · NICHD · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LEGRO, RICHARD S. · 2000 to 2017
$5.0M
Multiethnic Fine-Mapping of Polycystic Ovary Syndrome Susceptibility LociR01HD085227 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHEN, ZIJIANG, DUNAIF, ANDREA E · 2016 to 2020
$3.2M
The Inflammatory Response Pathway in the Etiology of Polycystic Ovary SyndromeR01HD057450 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI URBANEK, MARGRIT · 2009 to 2012
$2.1M
Medical Research Council G0802782Medical Research Council MC_U106179472Medical Research Council MC_UU_12015/2Medical Research Council MR/M012638/1Medical Research Council MR/N015355/1NCI NIH HHS P30 CA177558NCI NIH HHS UM1 CA186107NCRR NIH HHS UL1 RR025758NICHD NIH HHS P50 HD028138NICHD NIH HHS P50 HD044405NICHD NIH HHS R01 HD057223NICHD NIH HHS R01 HD057450NICHD NIH HHS R01 HD065029NICHD NIH HHS R01 HD085227NICHD NIH HHS U10 HD038992NIDDK NIH HHS P30 DK063491NIDDK NIH HHS U01 DK048381NIDDK NIH HHS U01 DK094431Wellcome Trust
6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed based on the two criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a fixed-effect, inverse-weighted-variance meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1), and provide replication of 11 previously reported loci. Only one locus differed significantly in its association by diagnostic criteria; otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or non-NIH Rotterdam criteria across common variants at 13 loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Linkage disequilibrium score regression analysis revealed genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease, indicating shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. The data thus demonstrate 3 novel loci associated with PCOS and similar genetic architecture for all diagnostic criteria. The data also provide the first genetic evidence for a male phenotype for PCOS and a causal link to depression, a previously hypothesized comorbid disease. Thus, the genetics provide a comprehensive view of PCOS that encompasses multiple diagnostic criteria, gender, reproductive potential and mental health.

Indexed as

Asian PeopleCase-Control StudiesCohort StudiesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPhenotypePolycystic Ovary SyndromeWhite People

Identifiers

PMID30566500
PMCPMC6300389
OpenAlexW2795286808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.